GSA CAPITAL PARTNERS LLP - ETON PHARMACEUTICALS INC ownership

ETON PHARMACEUTICALS INC's ticker is ETON and the CUSIP is 29772L108. A total of 34 filers reported holding ETON PHARMACEUTICALS INC in Q1 2022. The put-call ratio across all filers is 0.13 and the average weighting 0.2%.

Quarter-by-quarter ownership
GSA CAPITAL PARTNERS LLP ownership history of ETON PHARMACEUTICALS INC
ValueSharesWeighting
Q1 2022$107,000
-37.4%
24,475
-38.5%
0.01%
-33.3%
Q4 2021$171,000
-58.8%
39,817
-51.6%
0.02%
-50.0%
Q3 2021$415,000
+17.2%
82,314
+43.4%
0.04%
+5.0%
Q2 2021$354,000
+20.8%
57,397
+43.3%
0.04%
-18.4%
Q1 2021$293,00040,0640.05%
Other shareholders
ETON PHARMACEUTICALS INC shareholders Q1 2022
NameSharesValueWeighting ↓
Opaleye Management Inc. 4,040,000$32,845,0004.29%
AWM Investment Company, Inc. 971,681$7,900,0001.00%
Diametric Capital, LP 51,633$420,0000.33%
Mesirow Financial Investment Management, Inc. 1,046$8,504,0000.03%
Hood River Capital Management LLC 76,397$621,0000.02%
Westside Investment Management, Inc. 83,900$4,743,0000.01%
MML INVESTORS SERVICES, LLC 129,250$1,051,0000.01%
PRELUDE CAPITAL MANAGEMENT, LLC 31,961$260,0000.01%
TWO SIGMA INVESTMENTS, LP 126,490$1,028,0000.00%
SEI INVESTMENTS CO 76,397$621,0000.00%
View complete list of ETON PHARMACEUTICALS INC shareholders